Patents by Inventor Christian Kleist

Christian Kleist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240121561
    Abstract: A hearing aid device is disclosed. The hearing aid device comprises means to improve, augment and/or protect the hearing capability of a user by receiving acoustic signals from the surroundings of the user, generating corresponding audio signals, possibly modifying the audio signals and providing the possibly modified audio signals as audible signals to at least one of the user's ears. The hearing aid device comprises a sensor member for detecting the movement and/or acceleration and/or orientation (or spatial position) of the hearing aid device. The hearing aid device comprises at least two hearing aid microphones and a control unit for determining the position or a deviation from an intended position of the hearing aid device or hearing aid microphones. The hearing aid device is configured to compensate for a possible dislocation of the hearing aid microphones.
    Type: Application
    Filed: December 13, 2023
    Publication date: April 11, 2024
    Applicant: Oticon A/S
    Inventors: Michael Syskind PEDERSEN, Kenneth Rueskov MØLLER, Svend Oscar PETERSEN, Niels Stubager KIEMER, Jesper Kofoed NIELSEN, Björn OHL, Marianne Kleist ELMLUND, Karin CARVALHO, Henrik BENDSEN, Regin Kopp PEDERSEN, Christian C. BÜRGER, Steen Michael MUNK, Morten CHRISTOPHERSEN, Julie Hefting PEDERSEN, Bo WESTERGÅRD, Maria OXENBØLL
  • Patent number: 11554139
    Abstract: The present invention relates to pharmaceutical compositions with isolated and treated whole blood cells or Peripheral Blood Mononuclear Cells (PBMCs) as well as such pharmaceutical compositions for use in the prevention and/or treatment of organ or cell graft rejection in a human graft recipient.
    Type: Grant
    Filed: May 17, 2019
    Date of Patent: January 17, 2023
    Assignees: TOLEROGENIXX GMBH, UNIVERSITÄT HEIDELBERG
    Inventors: Christian Morath, Anita Schmitt, Matthias Schaier, Gerhard Opelz, Peter Terness, Christian Kleist, Volker Daniel, Caner Süsal, Michael Schmitt, Martin Zeier
  • Publication number: 20220118009
    Abstract: The present invention relates to pharmaceutical compositions with isolated and treated whole blood cells or Peripheral Blood Mononuclear Cells (PBMCs) as well as such pharmaceutical compositions for use in the prevention and/or treatment of organ or cell graft rejection in a human graft recipient.
    Type: Application
    Filed: May 17, 2019
    Publication date: April 21, 2022
    Inventors: Christian MORATH, Anita SCHMITT, Matthias SCHAIER, Gerhard OPELZ, Peter TERNESS, Christian KLEIST, Volker DANIEL, Caner SÜSAL, Michael SCHMITT, Martin ZEIER
  • Patent number: 11123368
    Abstract: The present invention refers to a method of producing immunosuppressive bleed cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: September 21, 2021
    Assignee: Universitatsklinikum Heidelberg
    Inventors: Peter Terness, Gerhard Opelz, Helmut Simon, Sandra Ehser, Christian Kleist, Flavius Sandra-Petrescu, Mircea Iancu, Lucian Jiga, Jing-Jing Chuang, Thilo Oelert
  • Publication number: 20170319619
    Abstract: The present invention refers to a method of producing immunosuppressive bleed cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
    Type: Application
    Filed: May 19, 2017
    Publication date: November 9, 2017
    Applicant: Universitatsklinikum Heidelberg
    Inventors: Peter TERNESS, Gerhard OPELZ, Helmut SIMON, Sandra EHSER, Christian KLEIST, Flavius SANDRA-PETRESCU, Mircea IANCU, Lucian JIGA, Jing-Jing CHUANG, Thilo OELERT
  • Publication number: 20150132326
    Abstract: The present invention refers to a method of producing immunosuppressive blood cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
    Type: Application
    Filed: November 7, 2014
    Publication date: May 14, 2015
    Applicant: Universitatsklinikum Heidelberg
    Inventors: Peter TERNESS, Gerhard OPELZ, Helmut SIMON, Sandra EHSER, Christian KLEIST, Flavius SANDRA-PETRESCU, Mircea IANCU, Lucian JIGA, Jing-Jing CHUANG, Thilo OELERT
  • Publication number: 20110223145
    Abstract: The present invention refers to a method of producing immunosuppressive blood cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
    Type: Application
    Filed: June 30, 2009
    Publication date: September 15, 2011
    Inventors: Peter Terness, Gerhard Opelz, Helmut Simon, Sandra Ehser, Christian Kleist, Flavius Sandra-Petrescu, Mircea Iancu, Lucian Jiga, Jing-Jing Chuang, Thilo Oelert